Please provide your email address to receive an email when new articles are posted on . Researchers reviewed the efficacy of ravulizumab based on 2-year data from two phase 3, single-arm studies. eGFR ...

Please provide your email address to receive an email when new articles are posted on . Registry data showed efficacy of ravulizumab was similar to that of eculizumab. No unexpected adverse events ...

A study links certain uremic toxins with cytokines and processes associated with red blood cell death in patients on dialysis. Specific uremic toxins may spur eryptosis and inflammation and contribute ...

For years, dialysis has been the standard treatment for uremia. However, regular, long-lasting therapy sessions tethered to an essentially unmovable machine are not ideal for patients. After ...

Atypical haemolytic uremic syndrome (aHUS) is an uncommon, yet potentially life‐threatening disorder predominantly characterised by dysregulation of the alternative complement pathway. Unlike the more ...